Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MEN 2A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 155 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hahm, JR; Lee, MS; Min, YK; Lee, MK; Kim, KW; Nam, SJ; Yang, JH; Chung, JH
      Routine measurement of serum calcitonin is useful for early detection of medullary thyroid carcinoma in patients with nodular thyroid diseases

      THYROID
    2. Alsanea, O; Clark, OH
      Familial thyroid cancer

      CURRENT OPINION IN ONCOLOGY
    3. Kalinin, VN; Amosenko, FA; Shabanov, MA; Lubchenko, LN; Hosch, SB; Garkavtseva, RF; Izbicki, JR
      Three novel mutations in the RET proto-oncogene

      JOURNAL OF MOLECULAR MEDICINE-JMM
    4. Huang, SM; Kuo, MS; Jin, YT; Liu, HT; Wang, WP
      Prophylactic total thyroidectomy in an 8-year-old girl with multiple endocrine neoplasia type 2A

      JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
    5. de Graaff, E; Srinivas, S; Kilkenny, C; D'Agati, V; Mankoo, BS; Costantini, F; Pachnis, V
      Differential activities of the RET tyrosine kinase receptor isoforms during mammalian embryogenesis

      GENES & DEVELOPMENT
    6. Siggelkow, H; Melzer, A; Nolte, W; Karsten, K; Hoppner, W; Hufner, M
      Presentation of a kindred with familial medullary thyroid carcinoma and Cys61 1Phe mutation of the RET proto-oncogene demonstrating low grade malignancy

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    7. Nguyen, L; Niccoli-Sire, P; Caron, P; Bastie, D; Maes, B; Chabrier, G; Chabre, O; Rohmer, V; Lecomte, P; Henry, JF; Conte-Devolx, B
      Pheochromocytoma in multiple endocrine neoplasia type 2: a prospective study

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    8. Carli, AF; Mariani, F; Di Cosmo, L; Giuli, R; Neri, A
      Familial medullary thyroid carcinoma (FMTC). Study of one family (treatment criteria)

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    9. Wiench, M; Wygoda, Z; Gubala, E; Wloch, J; Lisowska, K; Krassowski, J; Scieglinska, D; Fiszer-Kierzkowska, A; Lange, D; Kula, D; Zeman, M; Roskosz, J; Kukulska, A; Krawczyk, Z; Jarzab, B
      Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients

      JOURNAL OF CLINICAL ONCOLOGY
    10. Tommasi, M; Brocchi, A; Cappellini, A; Raspanti, S; Mannelli, M
      False serum calcitonin high levels using a non-competitive two-site IRMA

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    11. Mulligan, LM
      Multiple endocrine neoplasia type 2: Molecular aspects

      GENETIC DISORDERS OF ENDOCRINE NEOPLASIA
    12. Schuurman, B
      Unusual clinical presentation of a patient with multiple endocrine neoplasia type 2A

      NETHERLANDS JOURNAL OF MEDICINE
    13. Mograbi, B; Bocciardi, R; Bourget, I; Juhel, T; Farahi-Far, D; Romeo, G; Ceccherini, I; Rossi, B
      The sensitivity of activated Cys Ret mutants to glial cell line-derived neurotrophic factor is mandatory to rescue neuroectodermic cells from apoptosis

      MOLECULAR AND CELLULAR BIOLOGY
    14. Wohllk, N; Becker, P; Youlton, R; Cote, GJ; Gagel, RF
      Germline mutations of the ret proto-oncogen in Chilean patients with hereditary and sporadic medullary thyroid carcinoma

      REVISTA MEDICA DE CHILE
    15. Klein, I; Esik, O; Homolya, V; Szeri, F; Varadi, A
      Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary

      JOURNAL OF ENDOCRINOLOGY
    16. Niccoli-Sire, P; Murat, A; Rohmer, V; Franc, S; Chabrier, G; Baldet, L; Maes, B; Savagner, F; Giraud, S; Bezieau, S; Kottler, ML; Morange, S; Conte-Devolx, B
      Familial medullary thyroid carcinoma with noncysteine RET mutations: Phenotype-genotype relationship in a large series of patients

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    17. Quadro, L; Fattoruso, O; Cosma, MP; Verga, U; Porcellini, A; Libroia, A; Colantuoni, V
      Loss of heterozygosity at the RET protooncogene locus in a case of multiple endocrine neoplasia type 2A

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    18. Gimm, O; Dziema, H; Brown, J; De la Puente, A; Hoang-Vu, C; Dralle, H; Plass, C; Eng, C
      Mutation analysis of NTRK2 and NTRK3, encoding 2 tyrosine kinase receptors, in sporadic human medullary thyroid carcinoma reveals novel sequence variants

      INTERNATIONAL JOURNAL OF CANCER
    19. Chiefari, E; Chiarella, R; Crocetti, U; Tardio, B; Arturi, F; Russo, D; Trischitta, V; Filetti, S; Zingrillo, M
      A large family with hereditary MTC: Role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC

      HORMONE AND METABOLIC RESEARCH
    20. Iwashita, T; Kurokawa, K; Qiao, S; Murakami, H; Asai, N; Kawai, K; Hashimoto, M; Watanabe, T; Ichihara, M; Takahashi, M
      Functional analysis of RET with Hirschsprung mutations affecting its kinase domain

      GASTROENTEROLOGY
    21. Hennige, AM; Lammers, R; Hoppner, W; Arlt, D; Strack, V; Teichmann, R; Machicao, F; Ullrich, A; Haring, HU; Kellerer, M
      Inhibition of Ret oncogene activity by the protein tyrosine phosphatase SHP1

      ENDOCRINOLOGY
    22. de la Fuente, M; Quinteiro, C; Dominguez, F; Loidi, L
      LightCycler PCR assay for genotyping codon 634 mutations in the RET protooncogene

      CLINICAL CHEMISTRY
    23. Ruiz, A; Antinolo, G; Marcos, I; Borrego, S
      Novel technique for scanning of codon 634 of the RET protooncogene with fluorescence resonance energy transfer and real-time PCR in patients with medullary thyroid carcinoma

      CLINICAL CHEMISTRY
    24. Vitale, G; Caraglia, M; Ciccarelli, A; Lupoli, G; Abbruzzese, A; Tagliaferri, P; Lupoli, G
      Current approaches and perspectives in the therapy of medullary thyroid carcinoma

      CANCER
    25. Phay, JE; Moley, JF; Lairmore, TC
      Multiple endocrine neoplasias

      SEMINARS IN SURGICAL ONCOLOGY
    26. Bartsch, DK; Hasse, C; Schug, C; Barth, P; Rothmund, M; Hoppner, W
      A RET double mutation in the germline of a kindred with FMTC

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    27. Fukaya, H; Suzuki, C; Yasuta, H; Ohtani, I
      Temporal bone findings in multiple endocrine neoplasia type 2B

      EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY
    28. Pacini, F; Elisei, R; Romei, C; Pinchera, A
      RET proto-oncogene mutations in thyroid carcinomas: Clinical relevance

      JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
    29. Hennige, AM; Lammers, R; Arlt, D; Hoppner, W; Strack, V; Niederfellner, G; Seif, FJ; Haring, HU; Kellerer, M
      Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    30. Januszewicz, A; Neumann, HPH; Lon, I; Szmigielski, C; Symonides, B; Kabat, M; Apel, TW; Wocial, B; Lapinski, M; Januszewicz, W
      Incidence and clinical relevance of RET proto-oncogene germline mutations in pheochromocytoma patients

      JOURNAL OF HYPERTENSION
    31. Smith-Hicks, CL; Sizer, KC; Powers, JF; Tischler, AS; Costantini, F
      C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in amouse model of multiple endocrine neoplasia type 2B

      EMBO JOURNAL
    32. Grosfeld, FJM; Lips, CJM; Beemer, FA; Blijham, GH; Quirijnen, JMSP; Mastenbroek, MP; ten Kroode, HFJ
      Distress in MEN 2 family members and partners prior to DNA test disclosure

      AMERICAN JOURNAL OF MEDICAL GENETICS
    33. Feldman, GL; Edmonds, MW; Ainsworth, PJ; Schuffenecker, I; Lenoir, GM; Saxe, AW; Talpos, GB; Roberson, J; Petrucelli, N; Jackson, CE
      Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG -> ATG) mutation

      SURGERY
    34. Lecube, A; Hernandez, C; Oriola, J; Tovar, JL; Gemar, E; Baena, JA; Mesa, J; Simo, R
      Distinctive clinic features of pheochromocytoma in the setting of multipleendocrine neoplasia 2A

      MEDICINA CLINICA
    35. Diaz-Cano, SJ; de Miguel, M; Blanes, A; Tashjian, R; Galera, H; Wolfe, HJ
      Clonal patterns in phaeochromocytomas and MEN-2A adrenal medullary hyperplasias: histological and kinetic correlates

      JOURNAL OF PATHOLOGY
    36. Hansford, JR; Mulligan, LM
      Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis

      JOURNAL OF MEDICAL GENETICS
    37. Segouffin-Cariou, C; Billaud, M
      Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway

      JOURNAL OF BIOLOGICAL CHEMISTRY
    38. Colucci-D'Amato, GL; D'Alessio, A; Califano, D; Cali, G; Rizzo, C; Nitsch, L; Santelli, G; de Franciscis, V
      Abrogation of nerve growth factor-induced terminal differentiation by ret oncogene involves perturbation of nuclear translocation of ERK

      JOURNAL OF BIOLOGICAL CHEMISTRY
    39. Hansen, HS; Torring, H; Godballe, C; Jager, AC; Nielsen, FC
      Is thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome?

      CANCER
    40. Iwashita, T; Murakami, H; Kurokawa, K; Kawai, K; Miyauchi, A; Futami, H; Qiao, S; Ichihara, M; Takahashi, M
      A two-hit model for development of multiple endocrine neoplasia type 2B byRET mutations

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    41. Engelbach, M; Kunt, T; Kann, P; Manfras, B; Hankeln, T; Forst, T; Pfutzner, A; Heerdt, S; Walgenbach, S; Lehnert, H; Beyer, J
      Predictive molecular genetics in the diagnosis and treatment of families with multiple endocrine neoplasia type 2

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    42. Gimm, O; Dralle, H
      C-cell cancer - prevention and treatment

      LANGENBECKS ARCHIVES OF SURGERY
    43. Bockhorn, M; Frilling, A; Kalinin, V; Schroder, S; Broelsch, CE
      No correlation between RET immunostaining and the codon 918 mutation in sporadic medullary thyroid carcinoma

      LANGENBECKS ARCHIVES OF SURGERY
    44. de Graaf, JS; Lips, CJM; Rutter, JE; van Vroonhoven, TJMV
      Subtotal adrenalectomy for phaeochromocytoma in multiple endocrine neoplasia type 2A

      EUROPEAN JOURNAL OF SURGERY
    45. Iwashita, T; Kato, M; Murakami, H; Asai, N; Ishiguro, Y; Ito, S; Iwata, Y; Kawai, K; Asai, M; Kurokawa, K; Kajita, H; Takahashi, M
      Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma

      ONCOGENE
    46. Chang, TJ; Wu, SL; Chang, TC; Huang, SH; Chang, TJ
      De novo RET proto oncogene mutation in a patient with multiple endocrine neoplasia type 2B

      JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
    47. Akama, H; Noshiro, T; Kimura, N; Shimizu, K; Watanabe, T; Shibukawa, S; Nakai, S; Miura, W; Ito, S; Miura, Y
      Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene

      INTERNAL MEDICINE
    48. Dang, GT; Cote, GJ; Schultz, PN; Khorana, S; Decker, RA; Gagel, RF
      A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma: a detection strategy

      MOLECULAR AND CELLULAR PROBES
    49. Mayr, B; Brabant, G; von zur Muhlen, A
      Incidental detection of familial medullary thyroid carcinoma by calcitoninscreening for nodular thyroid disease

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    50. Eng, C
      RET proto-oncogene in the development of human cancer

      JOURNAL OF CLINICAL ONCOLOGY
    51. Kroustrup, JP; Laurberg, P; Madsen, PH
      Rapid MEN 2A gene carrier identification using primer-specific PCR amplification

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    52. Heptulla, RA; Schwartz, RP; Bale, AE; Flynn, D; Genel, M
      Familial medullary thyroid carcinoma: Presymptomatic diagnosis and management in children

      JOURNAL OF PEDIATRICS
    53. van Heurn, LWE; Schaap, C; Sie, G; Haagen, AAM; Gerver, WJ; Freling, G; van Amstel, HKP; Heineman, E
      Predictive DNA testing for multiple endocrine neoplasia 2: A therapeutic challenge of prophylactic thyroidectomy in very young children

      JOURNAL OF PEDIATRIC SURGERY
    54. Iler, MA; King, DR; Ginn-Pease, ME; O'Dorisio, TM; Sotos, JF
      Multiple endocrine neoplasia type 2A: A 25-year review

      JOURNAL OF PEDIATRIC SURGERY
    55. Pigny, P; Bauters, C; Wemeau, JL; Houcke, ML; Crepin, M; Caron, P; Giraud, S; Calender, A; Buisine, MP; Kerckaert, JP; Porchet, N
      A novel 9-base pair duplication in RET exon 8 in familial medullary thyroid carcinoma

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    56. Ponder, BAJ
      The phenotypes associated with ret mutations in the multiple endocrine neoplasia type 2 syndrome

      CANCER RESEARCH
    57. Nakayama, S; Iida, K; Tsuzuki, T; Iwashita, T; Murakami, H; Asai, N; Iwata, Y; Ichihara, M; Ito, S; Kawai, K; Asai, M; Kurokawa, K; Takahashi, M
      Implication of expression of GDNF/Ret signalling components in differentiation of bone marrow haemopoietic cells

      BRITISH JOURNAL OF HAEMATOLOGY
    58. Noll, WW
      Utility of RET mutation analysis in multiple endocrine neoplasia type 2

      ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
    59. SHIRAHAMA S; OGURA K; TAKAMI H; ITO K; TOHSEN T; MIYAUCHI A; NAKAMURA Y
      MUTATIONAL ANALYSIS OF THE RET PROTOONCOGENE IN 71 JAPANESE PATIENTS WITH MEDULLARY-THYROID CARCINOMA

      JOURNAL OF HUMAN GENETICS
    60. FALCHETTI A; BRANDI ML
      GENETIC TESTING FOR MULTIPLE ENDOCRINE NEOPLASIAS

      Endocrine-related cancer
    61. FATTORUSO O; QUADRO L; LIBROIA A; VERGA U; LUPOLI G; CASCONE E; COLANTUONI V
      A GTG TO ATG NOVEL POINT MUTATION AT CODON-804 IN EXON-14 OF THE RET PROTOONCOGENE IN 2 FAMILIES AFFECTED BY FAMILIAL MEDULLARY-THYROID CARCINOMA

      Human mutation
    62. BERESSI N; CAMPOS JM; BERESSI JP; FRANC B; NICCOLISIRE P; CONTEDEVOLX B; MURAT A; CARON P; BALDET L; KRAIMPS JL; COHEN R; BIGORGNE JC; CHABRE O; LECOMTE P; MODIGLIANI E
      SPORADIC MEDULLARY MICROCARCINOMA OF THE THYROID - A RETROSPECTIVE ANALYSIS OF 80 CASES

      Thyroid
    63. TANG NLS; YEUNG VTF; COCKRAM CS; PANG CP
      DETERMINATION OF THE RISK FOR FAMILIAL DISEASE IN RET MUTATION-NEGATIVE PATIENTS WITH MEDULLARY-THYROID CANCER

      Journal of internal medicine
    64. ENG C; MYERS SM; KOGON MD; SANICOLA M; HESSION C; CATE RL; MULLIGAN LM
      GENOMIC STRUCTURE AND CHROMOSOMAL LOCALIZATION OF THE HUMAN GDNFR-ALPHA GENE

      Oncogene
    65. HINZE R; HOLZHAUSEN HJ; GIMM O; DRALLE H; RATH FW
      PRIMARY HEREDITARY MEDULLARY-THYROID CARCINOMA - C-CELL MORPHOLOGY AND CORRELATION WITH PREOPERATIVE CALCITONIN LEVELS

      Virchows Archiv
    66. WU SL; CHANG TC; HUANG CN; CHUANG LM; CHANG TJ
      GERMLINE RET PROTOONCOGENE MUTATIONS IN 2 TAIWANESE FAMILIES WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A

      Journal of the Formosan Medical Association
    67. HUANG CN; WU SL; CHANG TC; HUANG SH; CHANG TJ
      RET PROTOONCOGENE MUTATIONS IN PATIENTS WITH APPARENTLY SPORADIC MEDULLARY-THYROID CARCINOMA

      Journal of the Formosan Medical Association
    68. GIUFFRIDA D; GHARIB H
      CURRENT DIAGNOSIS AND MANAGEMENT OF MEDULLARY-THYROID CARCINOMA

      Annals of oncology
    69. KATAI M; SAKURAI A; ICHIKAWA K; YAMAGATA M; OGISO Y; KOBAYASHI S; HASHIZUME K
      PHEOCHROMOCYTOMA ARISING FROM AN ACCESSORY ADRENAL-GLAND IN A PATIENTWITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A - TRANSIENT DEVELOPMENT OF CLINICAL MANIFESTATIONS AFTER HEMORRHAGIC NECROSIS

      Endocrine journal
    70. KARGA HJ; KARAYIANNI MK; LINOS DA; TSELENI SC; KARAISKOS KD; PAPAPETROU PD
      GERM-LINE MUTATION ANALYSIS IN FAMILIES WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A OR FAMILIAL MEDULLARY-THYROID CARCINOMA

      European journal of endocrinology
    71. HIDALGO A; MEDRANO ME; RODRIGUEZ S; FRANCO C; MARTINEZ I; BENITEZ L; SALCEDO M
      PRESENCE OF THE 918-MUTATION IN THE RET PROTOONCOGENE IN A MEXICAN PATIENT WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE-2B

      Journal of experimental & clinical cancer research
    72. LIBROIA A; VERGA U; VECCHI G; BANFI F; ZURLENI F; QUADRO L; SCURINI C; FATTORUSO O; COLANTUONI V
      17-YEAR-LONG FOLLOW-UP OF A FAMILY AFFECTED BY TYPE 2A MULTIPLE ENDOCRINE NEOPLASIA (MEN 2A)

      Journal of endocrinological investigation
    73. EGAWA S; FUTAMI H; TAKASAKI K; IIHARA M; OKAMOTO T; KANBE M; OHI T; SAIO Y; MIYAUCHI A; TAKIYAMA Y; KOGA M; MIYANAGA K; INOUE K; MITSUYAMA S; NOMURA Y; TAKEI H; MUGIYA S; ISHIDA O; ZEZE F; SHAKUTSUI S; INOUE H; OYA H; YOSHIMURA A; ISHIZUKA S; TSUJINO T; OBARA T; YAMAGUCHI K
      GENOTYPE-PHENOTYPE CORRELATION OF PATIENTS WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 IN JAPAN

      Japanese Journal of Clinical Oncology
    74. DRALLE H; GIMM O; SIMON D; FRANKRAUE K; GORTZ G; NIEDERLE B; WAHL RA; KOCH B; WALGENBACH S; HAMPEL R; RITTER MM; SPELSBERG F; HEISS A; HINZE R; HOPPNER W
      PROPHYLACTIC THYROIDECTOMY IN 75 CHILDREN AND ADOLESCENTS WITH HEREDITARY MEDULLARY-THYROID CARCINOMA - GERMAN AND AUSTRIAN EXPERIENCE

      World journal of surgery
    75. SCURINI C; QUADRO L; FATTORUSO O; VERGA U; LIBROIA A; LUPOLI G; CASCONE E; MARZANO L; PARACCHI S; BUSNARDO B; GIRELLI ME; BELLASTELLA A; COLANTUONI V
      GERMLINE AND SOMATIC MUTATIONS OF THE RET PROTOONCOGENE IN APPARENTLYSPORADIC MEDULLARY-THYROID CARCINOMAS

      Molecular and cellular endocrinology
    76. PEGORARO RJ; HACKING DJ; BUCK RH; LANNING PA; BERGER GMB
      MOLECULAR DIAGNOSIS MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A

      South African medical journal
    77. ORIOLA J; PARAMO C; HALPERIN I; GARCIAMAYOR RV; RIVERAFILLAT F
      NOVEL POINT MUTATION IN EXON-10 OF THE RET PROTOONCOGENE IN A FAMILY WITH MEDULLARY-THYROID CARCINOMA

      American journal of medical genetics
    78. Attie-Bitach, T; Abitbol, M; Gerard, M; Delezoide, AL; Auge, J; Pelet, A; Amiel, J; Pachnis, V; Munnich, A; Lyonnet, S; Vekemans, M
      Expression of the RET proto-oncogene in human embryos

      AMERICAN JOURNAL OF MEDICAL GENETICS
    79. Rafecas, A; Ribas, Y; Villabona, C; Viladrich, M; Figueras, J; Fabregat, J; Torras, J; Gomez, JM; Jaurrieta, E
      Usefulness of the genetic screening in the diagnosis of medullary thyroid carcinoma

      MEDICINA CLINICA
    80. SCHUFFENECKER I; VIRALLYMONOD M; BROHET R; GOLDGAR D; CONTEDEVOLX C; LECLERC L; CHABRE O; BONEU A; CARON J; HOUDENT C; MODIGLIANI E; ROHMER V; SCHLUMBERGER M; ENG C; GUILLAUSSEAU PJ; LENOIR GM
      RISK AND PENETRANCE OF PRIMARY HYPERPARATHYROIDISM IN MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A FAMILIES WITH MUTATIONS AT CODON-634 OF THE RET PROTOONCOGENE

      The Journal of clinical endocrinology and metabolism
    81. Eng, C; Thomas, GA; Neuberg, DS; Mulligan, LM; Healey, CS; Houghton, C; Frilling, A; Raue, F; Williams, ED; Ponder, BAJ
      Mutation of the RET proto-oncogene is correlated with RET immunostaining in subpopulations of cells in sporadic medullary thyroid carcinoma

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    82. O'Keeffe, DA; Hill, ADK; Sheahan, K; Ryan, F; Barton, D; Fitzgerald, RJ; McDermott, EW; O'Higgins, NJ
      Ret-proto-oncogene analysis in medullary thyroid carcinoma

      IRISH JOURNAL OF MEDICAL SCIENCE
    83. FRILLING A; LIEDKE MO
      MEDULLARY-THYROID CARCINOMA - SPORADIC FA MILIAL - WHEN AND WHY SHOULD WE SCREEN/

      Der Internist
    84. KALININ BN; AMOSENKO FA; PUSHKASH K; FRILLING A; BRELSH KE
      A NEW INHERITED RET PROTOONCOGENE MUTATION ASSOCIATED WITH FAMILIAL MEDULLARY-THYROID CARCINOMA AND POLYMORPHISMS IN THE ADJACENT REGIONS

      Genetika
    85. HERFARTH KK; WELLS SA
      PARATHYROID-GLANDS AND THE MULTIPLE ENDOCRINE NEOPLASIA SYNDROMES ANDFAMILIAL HYPOCALCIURIC HYPERCALCEMIA

      Seminars in surgical oncology
    86. HALLING KC; BUFILL JA; COTTER M; ARTZ SA; CARPENTER AB; SCHAID D; HARTMANADAMS H; CHANG HH; BOUSTANY MM; FITHIAN L; JHIANG SM; THIBODEAU SN
      AGE-RELATED DISEASE PENETRANCE IN A LARGE MEDULLARY-THYROID CANCER FAMILY WITH A CODON-609 RET GENE MUTATION

      Molecular diagnosis
    87. SERI M; YIN L; BARONE V; BOLINO A; CELLI I; BOCCIARDI R; PASINI B; CECCHERINI I; LERONE M; KRISTOFFERSSON U; LARSSON LT; CASASA JM; CASS DT; ABRAMOWICZ MJ; VANDERWINDEN JM; KRAVCENKIENE I; BARIC I; SILENGO M; MARTUCCIELLO G; ROMEO G
      FREQUENCY OF RET MUTATIONS IN LONG-SEGMENT AND SHORT-SEGMENT HIRSCHSPRUNG DISEASE

      Human mutation
    88. ENG C; MULLIGAN LM
      MUTATIONS OF THE RET PROTOONCOGENE IN THE MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 SYNDROMES, RELATED SPORADIC TUMORS, AND HIRSCHSPRUNG DISEASE

      Human mutation
    89. PERETZ H; LUBOSHITSKY R; BARON E; BITON A; GERSHONI R; USHER S; GRYNBERG E; YAKOBSON E; GRAFF E; LAPIDOT M
      CYS-618 ARG MUTATION IN THE RET PROTOONCOGENE ASSOCIATED WITH FAMILIAL MEDULLARY-THYROID CARCINOMA AND MATERNALLY TRANSMITTED HIRSCHSPRUNGS-DISEASE SUGGESTING A ROLE FOR IMPRINTING

      Human mutation
    90. WOODWARD ER; ENG C; MCMAHON R; VOUTILAINEN R; AFFARA NA; PONDER BAJ; MAHER ER
      GENETIC PREDISPOSITION TO PHEOCHROMOCYTOMA - ANALYSIS OF CANDIDATE GENES GDNF, RET AND VHL

      Human molecular genetics
    91. PASINI A; GENESTE O; LEGRAND P; SCHLUMBERGER M; ROSSEL M; FOURNIER L; RUDKIN BB; SCHUFFENECKER I; LENOIR GM; BILLAUD M
      ONCOGENIC ACTIVATION OF RET BY 2 DISTINCT FMTC MUTATIONS AFFECTING THE TYROSINE KINASE DOMAIN

      Oncogene
    92. KITAMURA Y; GOODFELLOW PJ; SHIMIZU K; NAGAHAMA M; ITO K; KITAGAWA W; AKASU H; TAKAMI H; TANAKA S; WELLS SA
      NOVEL GERMLINE RET PROTOONCOGENE MUTATIONS ASSOCIATED WITH MEDULLARY-THYROID CARCINOMA (MTC) - MUTATION ANALYSIS IN JAPANESE PATIENTS WITH MTC

      Oncogene
    93. ALEMI M; LUCAS SD; SALLSTROM JF; BERGHOLM U; AKERSTROM G; WILANDER E
      A COMPLEX 9 BASE-PAIR DELETION IN RET EXON-11 COMMON IN SPORADIC MEDULLARY-THYROID CARCINOMA

      Oncogene
    94. KOMMINOTH P
      THE RET PROTOONCOGENE IN MEDULLARY AND PAPILLARY THYROID-CARCINOMA - MOLECULAR-FEATURES, PATHOPHYSIOLOGY AND CLINICAL IMPLICATIONS

      Virchows Archiv
    95. HESHMATI HM; HOFBAUER LC
      MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 - RECENT PROGRESS IN DIAGNOSIS AND MANAGEMENT

      European journal of endocrinology
    96. BUGALHO MJ; FRADE JP; SANTOS JR; LIMBERT E; SOBRINHO L
      MOLECULAR ANALYSIS OF THE RET PROTOONCOGENE IN PATIENTS WITH SPORADICMEDULLARY-THYROID CARCINOMA - A NOVEL POINT MUTATION IN THE EXTRACELLULAR CYSTEINE-RICH DOMAIN

      European journal of endocrinology
    97. IIHARA M; YAMASHITA T; OKAMOTO T; KANBE M; YAMAZAKI K; EGAWA S; YAMAGUCHI K; OBARA T
      A NATIONWIDE CLINICAL SURVEY OF PATIENTS WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 AND FAMILIAL MEDULLARY-THYROID CARCINOMA IN JAPAN

      Japanese Journal of Clinical Oncology
    98. YAMASHITA T; IIHARA M; OKAMOTO J; KANBE M; ITO Y; KAWAKAMI M; EGAWA S; YAMAGUCHI K; OBARA T
      TREATMENT OF MINUTE MEDULLARY-THYROID CARCINOMA IN MULTIPLE ENDOCRINENEOPLASIA 2A FAMILIES FIRST DIAGNOSED BY DNA ANALYSIS OF RET PROTOONCOGENE MUTATIONS - A CASE-REPORT

      Japanese Journal of Clinical Oncology
    99. MARSH DJ; MULLIGAN LM; ENG C
      RET PROTOONCOGENE MUTATIONS IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-2 AND MEDULLARY-THYROID CARCINOMA

      Hormone research
    100. CALENDER A; GIRAUD S; SCHUFFENECKER I; LENOIR GM; GAUDRAY P; COURSEAUX A; PORCHET N; AUBERT JP; ZHANG CX
      GENETIC TESTING IN PRESYMPTOMATIC DIAGNOSIS OF MULTIPLE ENDOCRINE NEOPLASIA

      Hormone research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 03:18:47